"#Ensovibep unsuccessful in phase III trial of hospitalized adults w #COVID19. The odds ratio for a better pulmonary outcome in the ensovibep group at day 5 was 0.93 (95% CI, 0.67 to 1.30; P = 0.68; Odds Ratio &gt; 1 would favor ensovibep) vs placebo. https://t.co/FxN2awupOF"